Fenofibrate 48mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To ensure you get the most benefit from your medication, follow these steps:
Take your medication exactly as directed by your doctor. Read all the information provided with your prescription and follow the instructions carefully.
Check with your pharmacist to see if your specific brand of medication should be taken with food or if it can be taken with or without food.
If you have difficulty swallowing, consult with your doctor for guidance.
Take your medication with a full glass of water.
If you are taking cholestyramine or colestipol, be sure to take them at least 4 hours before or 1 hour after your medication.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel better.
Swallow your medication whole; do not chew, break, or crush it.
Do not take any tablets that are chipped or broken.
Storing and Disposing of Your Medication
To keep your medication effective and safe:
Store your medication at room temperature with the lid tightly closed.
Some brands of medication must be stored in their original container. Do not remove the anti-moisture cube or packet. If you are unsure, consult with your doctor or pharmacist.
What to Do if You Miss a Dose
If you miss a dose, follow these steps:
Skip the missed dose and return to your regular dosing schedule.
Do not take more than one dose in a 24-hour period, unless your doctor instructs you to do so.
Lifestyle & Tips
- Take this medication exactly as prescribed, usually once daily with food.
- Continue to follow a low-fat, low-cholesterol diet as recommended by your doctor.
- Engage in regular physical activity as advised by your healthcare provider.
- Limit alcohol intake, as it can increase triglyceride levels and potentially worsen liver side effects.
- Maintain a healthy weight.
Available Forms & Alternatives
Available Strengths:
- Fenofibrate 43mg Capsules
- Fenofibrate 130mg Capsules
- Fenofibrate 130mg Capsules
- Fenofibrate 43mg Capsules
- Fenofibrate 120mg Tablets
- Fenofibrate 40mg Tablets
- Fenofibrate 50mg Capsules
- Fenofibrate 120mg Tablets
- Fenofibrate 150mg Capsules
- Fenofibrate 40mg Tablets
- Fenofibrate 145mg Tablets
- Fenofibrate 48mg Tablets
- Fenofibrate 134mg Capsules
- Fenofibrate 200mg Capsules
- Fenofibrate 67mg Capsules
- Fenofibrate 160mg Tablets
- Fenofibrate 145mg Tablets
- Fenofibrate 134mg Capsules
- Fenofibrate 54mg Tablets
- Fenofibrate 200mg Capsules
- Fenofibrate 67mg Capsules
- Fenofibrate Micro 90mg Capsules
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat. In rare cases, allergic reactions can be life-threatening.
Liver Problems: Dark urine, tiredness, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
Pancreas Problems (Pancreatitis): Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Gallstones: Sudden pain in the upper right belly area, right shoulder area, or between the shoulder blades, yellow skin or eyes, or fever with chills.
Severe Joint Pain or Swelling: Contact your doctor if you experience very bad joint pain or swelling.
Blood Clots: Chest pain or pressure, coughing up blood, shortness of breath, swelling, warmth, numbness, change of color, or pain in a leg or arm, or trouble speaking or swallowing.
Muscle Problems: Muscle pain or weakness, especially if you feel very tired or weak or have a fever. This can also lead to kidney problems. Inform your doctor if you have difficulty urinating or notice a change in your urine output.
Severe Skin Reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions can occur, which may affect body organs and can be deadly. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or any areas of skin; fever; chills; body aches; shortness of breath; or swollen glands.
Low Blood Cell Counts: This can lead to bleeding problems, infections, or anemia. Contact your doctor if you have signs of infection like fever, chills, or sore throat; any unexplained bruising or bleeding; or if you feel very tired or weak.
Other Side Effects
Most people do not experience significant side effects, but some may occur. If you are concerned about any of the following side effects or if they persist, contact your doctor:
Headache
Back pain
Stomach pain
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Muscle pain, tenderness, or weakness (especially if accompanied by fever or unusual tiredness) β report immediately.
- Severe stomach pain, with or without nausea and vomiting (could be pancreatitis or gallstones).
- Yellowing of your skin or eyes (jaundice), dark urine, or light-colored stools (signs of liver problems).
- Unusual bleeding or bruising (if taking blood thinners).
- Signs of an allergic reaction: rash, hives, swelling of your face, lips, tongue, or throat, difficulty breathing.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the symptoms you experienced.
Certain health conditions, such as:
+ Gallbladder disease
+ Kidney disease
+ Liver disease
+ Elevated liver enzymes
If you are taking any of the following medications:
+ Atorvastatin
+ Fluvastatin
+ Lovastatin
+ Pitavastatin
+ Pravastatin
+ Rosuvastatin
+ Simvastatin
If you are breastfeeding or plan to breastfeed. Note that you should not breastfeed while taking this medication, and you may need to avoid breastfeeding for 5 days after your last dose. Consult your doctor to determine the best course of action.
Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to:
Inform your doctor and pharmacist about all medications you are taking, including prescription and over-the-counter medications, natural products, and vitamins.
Discuss all your health problems with your doctor.
Verify that it is safe to take this medication with all your other medications and health conditions.
Do not start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Be aware that this medication can cause liver problems, which in some cases may be severe, potentially leading to the need for a liver transplant or resulting in death. If you have any concerns or questions, discuss them with your doctor.
If you are 65 years or older, exercise caution when using this drug, as you may be more susceptible to experiencing side effects.
If you are pregnant or planning to become pregnant, notify your doctor. It is crucial to discuss the potential benefits and risks associated with using this medication during pregnancy to make an informed decision.
Overdose Information
Overdose Symptoms:
- No specific symptoms of overdose have been reported, but potential effects could include severe gastrointestinal upset, liver dysfunction, or muscle toxicity.
What to Do:
There is no specific antidote for fenofibrate overdose. Treatment should be symptomatic and supportive. Hemodialysis is not effective in removing fenofibric acid. Call 1-800-222-1222 (Poison Control Center) immediately or seek emergency medical attention.
Drug Interactions
Major Interactions
- Statins (HMG-CoA reductase inhibitors): Increased risk of myopathy/rhabdomyolysis. Use with caution, consider lower doses of statin, and monitor for muscle symptoms and CK levels.
- Oral anticoagulants (e.g., Warfarin): Potentiates anticoagulant effect, increasing risk of bleeding. Reduce anticoagulant dose and monitor INR frequently.
- Cyclosporine: May impair renal function, leading to increased fenofibric acid levels and potential for toxicity. Monitor renal function and fenofibric acid levels.
Moderate Interactions
- Colchicine: Increased risk of myopathy/rhabdomyolysis. Use with caution.
- Bile acid sequestrants (e.g., Cholestyramine, Colestipol): May decrease fenofibrate absorption. Administer fenofibrate at least 1 hour before or 4-6 hours after the bile acid sequestrant.
- Glitazones (e.g., Pioglitazone, Rosiglitazone): Potential for additive effects on lipid parameters, but also increased risk of fluid retention and heart failure. Use with caution.
Monitoring
Baseline Monitoring
Rationale: To establish baseline lipid levels and assess the need for therapy.
Timing: Prior to initiation of therapy
Rationale: To assess baseline liver function, as fenofibrate can cause transaminase elevations and is contraindicated in active liver disease.
Timing: Prior to initiation of therapy
Rationale: To assess baseline renal function, as fenofibrate is primarily renally eliminated and dose adjustments are required in renal impairment.
Timing: Prior to initiation of therapy
Rationale: To assess for potential hematologic abnormalities, though rare.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Every 4-8 weeks initially, then every 6-12 months once stable
Target: Individualized based on treatment goals (e.g., LDL-C < 100 mg/dL, Triglycerides < 150 mg/dL)
Action Threshold: If lipid goals not met or adverse changes observed, consider dose adjustment or alternative therapy.
Frequency: Every 3 months for the first year, then periodically (e.g., every 6-12 months) or as clinically indicated
Target: Within normal limits
Action Threshold: Discontinue if ALT or AST levels exceed 3 times the upper limit of normal (ULN) or if accompanied by symptoms of liver injury.
Frequency: Periodically (e.g., every 6-12 months) or as clinically indicated, especially in elderly or those with pre-existing renal impairment
Target: Stable, within acceptable limits
Action Threshold: If significant increase in creatinine or decrease in eGFR, consider dose reduction or discontinuation.
Frequency: As clinically indicated (e.g., if muscle pain, tenderness, or weakness occurs)
Target: Within normal limits
Action Threshold: Discontinue if CK levels are significantly elevated (e.g., >5x ULN) or if muscle symptoms are severe.
Symptom Monitoring
- Unexplained muscle pain, tenderness, or weakness (especially if accompanied by fever or malaise)
- Abdominal pain, nausea, vomiting (signs of pancreatitis or gallstones)
- Yellowing of skin or eyes (jaundice), dark urine, light-colored stools (signs of liver problems)
- Unusual fatigue or weakness
- Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Special Patient Groups
Pregnancy
Use during pregnancy should be avoided unless the potential benefit justifies the potential risk to the fetus. Limited human data suggest no increased risk of major birth defects, but animal studies show adverse effects at high doses.
Trimester-Specific Risks:
Lactation
It is not known whether fenofibric acid is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Use is generally not recommended.
Geriatric Use
No overall differences in safety or effectiveness have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Renal function should be monitored.
Clinical Information
Clinical Pearls
- Fenofibrate 48mg is a micronized or nanocrystallized formulation, which has improved bioavailability compared to older, non-micronized formulations. It is not directly interchangeable milligram-for-milligram with older formulations (e.g., 160mg).
- Always take fenofibrate with food to optimize absorption and efficacy.
- Monitor liver function tests (LFTs) and renal function regularly, especially during the first year of treatment.
- Educate patients on the signs and symptoms of myopathy (muscle pain, weakness) and pancreatitis (severe abdominal pain) and instruct them to report these immediately.
- Fenofibrate can potentiate the effects of warfarin; close INR monitoring and dose adjustment of warfarin are crucial when initiating or discontinuing fenofibrate.
- While fibrates can raise HDL-C and lower triglycerides, their primary role in cardiovascular risk reduction is often debated, and they are typically used when triglycerides are very high or in combination with statins for mixed dyslipidemia, with careful consideration of risks.
Alternative Therapies
- Other Fibrates (e.g., Gemfibrozil)
- Statins (HMG-CoA reductase inhibitors) for hypercholesterolemia
- Omega-3 Fatty Acid Esters (e.g., Icosapent ethyl, Omega-3-acid ethyl esters) for hypertriglyceridemia
- PCSK9 Inhibitors (for severe hypercholesterolemia)
- Niacin (Nicotinic Acid) for dyslipidemia (less commonly used due to side effects)
- Bile Acid Sequestrants (for hypercholesterolemia)